A prognostic six‐gene expression risk‐score derived from proteomic profiling of the metastatic colorectal cancer secretome

A prognostic six‐gene expression risk‐score derived from proteomic profiling of the metastatic colorectal cancer secretome

Abstract The necessity to accurately predict recurrence and clinical outcome in early stage colorectal cancer (CRC) is critical to identify those patients who may benefit from adjuvant chemotherapy. Here, we developed and validated a gene‐based risk‐score algorithm for patient stratification and per...

Description complète

Détails bibliographiques
Auteurs principaux: Javier Robles, Laura Pintado‐Berninches, Issam Boukich, Beatriz Escudero, Vivian de losRios, Rubén A Bartolomé, Marta Jaén, Ángela Martín‐Regalado, María Jesús Fernandez‐Aceñero, Juan Ignacio Imbaud, José Ignacio Casal
Format: Article
Langue:English
Publié: Wiley 2022-11-01
Collection:The Journal of Pathology: Clinical Research
Sujets:
colorectal cancer metastasis
secreted proteins
risk‐score
prognostic signature
patient stratification
Accès en ligne:https://doi.org/10.1002/cjp2.294

Internet

https://doi.org/10.1002/cjp2.294

Documents similaires